Month: September 2023

Paris, September 25, 2023 The Air France-KLM Group will place an order for 50 Airbus A350 family aircraft – with purchase rights for 40 additional aircraft – to accelerate the renewal of its long-haul fleetAir France-KLM to become the world’s largest operator of the Airbus A350 family aircraft.The Air France-KLM Group today announced that it plans to place a landmark aircraft order to pursue the renewal and rationalization of its long-haul fleet, to the benefit of the Group’s environmental and economic performance. This Group order will cover 50 Airbus A350-900 and A350-1000 aircraft – with purchase rights for 40 additional aircraft – with first deliveries expected in 2026 through to 2030. This will be an evolutionary order, providing the Group with flexibility to allocate aircraft within its portfolio of airlines,...

FUCHS/L.B. FosterStefan Fuchs – Chairman of the Executive Board of FUCHS SE, and John Kasel – President and CEO, L.B. Foster CompanyFUCHS/L.B. FosterStefan Fuchs – Chairman of the Executive Board of FUCHS SE, and John Kasel – President and CEO, L.B. Foster Company alongside their management teams at the FUCHS main office in Mannheim, GermanyStefan Fuchs – Chairman of the Executive Board of FUCHS SE, and John Kasel – President and CEO, L.B. Foster Company Stefan Fuchs – Chairman of the Executive Board of FUCHS SE, and John Kasel – President and CEO, L.B. Foster Company alongside their management teams at the FUCHS main office in Mannheim, Germany PITTSBURGH, Sept. 25, 2023 (GLOBE NEWSWIRE) — L.B. Foster Company (Nasdaq: FSTR), a global technology solutions provider of products and services for the rail and infrastructure...

SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will present a poster on the Company’s anti-CD27 agonist antibody program at the American Association for Cancer Research (AACR) Special Conference on Tumor Immunology and Immunotherapy, to be held on October 1-4, 2023 in Toronto, ON, Canada. Thierry Guillaudeux, Ph.D., Chief Scientific Officer of Kineta, will be presenting new preclinical data on the company’s anti-CD27 agonist antibodies in development for the treatment of advanced solid tumors. Presentation Details:Poster Title: CD27 is a new promising T cell co-stimulatory target for cancer immunotherapyPoster Number: B034Session: Poster Session...

New AI app answers age old question: ‘what shall I cook for dinner tonight?’ London, UK, Sept. 25, 2023 (GLOBE NEWSWIRE) — Synthia AI can now help busy individuals solve their mundane, daily culinary dilemmas in a couple of minutes.  The whole-life AI assistant from UK tech incubator company Online Blockchain plc can:Provide meal inspiration from a very simple prompt  Quickly deliver recipe/s according to your preferences   Give ‘Ready Steady Cook’-style ideas based on ingredients you already have  Suggest vegetarian and vegan adaptations  Recommend substitute ingredients  Synthia AI will provide different answers according to knowledge built up about her ‘employer.’ When asked by one alpha tester: ‘What should I have for dinner tonight? I fancy something spicy,’ Synthia offered some tasty suggestions: Spicy Thai Basil...

IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been made by the Company in the U.K. for Nymozarfex (TM) for the treatment of benign prostatic hyperplasia (BPH). The Marketing Authorization Application (MAA) was submitted to the U.K. Medicines & Healthcare products Regulatory Agency (MHRA). The new submission includes England, Wales, Scotland and Northern Ireland. The Company will provide further information, including with respect to other submissions for Nymozarfex (TM), when the information becomes available. Paul Averback MD, CEO of Nymox said, “We thank our team members and many very important expert collaborators for their efforts and perseverance involved in the ongoing process....

WESTLAKE VILLAGE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage company focused on developing meaningful innovations in immuno-dermatology, today announced the launch of an educational campaign designed to elevate understanding, connection, and encouragement for those living with seborrheic dermatitis, or Seb Derm for short. The campaign, Clearing Up Seb Derm, features expert advice from leading dermatologists and personal stories from individuals living with seborrheic dermatitis. Clearing Up Seb Derm sheds light on the lack of information and understanding of seborrheic dermatitis, and how this condition has an impact beyond the skin, affecting people’s everyday lives. The campaign also aims to raise awareness that Seb Derm symptoms can vary from person to person,...

Image 1Plan Map of Recent DrillingImage 2Zoomed in Map of MIK DrillingImage 3Silt Sample Assay MapImage 4Field Work MapVANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V:WHN) is pleased to provide an exploration update on its 17,623-hectare Shovelnose gold property. Shovelnose is located within the prospective Spences Bridge Gold Belt (SBGB), which borders the Coquihalla Highway 30 kilometres south of Merritt, British Columbia. Highlights from the ongoing program include:MIK hole SN23-360 intersected 3.68 metres (m) of 17.61 g/t gold (Au) and 31.49 g/t silver (Ag), including 1.65m of 27.6 g/t Au. Five drill holes from MIK are pending assays. MIK hole SN23-362 intersected 2.44m of 3.43 g/t gold and 15.65 g/t silver, including 0.44m of 12.9 g/t Au and 73.2...

The Mullen THREE, Class 3 EV Cab Chassis Truck, starting at $68,500 MSRP, before available federal tax incentivesThe Mullen THREE is produced in Tunica, Mississippi, which is home to Mullen’s commercial vehicle assembly plant.EPA certification is a critical milestone to allow shipping vehicles to customers;Company’s first Class 3 EV Cab Chassis Trucks began rolling off the production line on Aug. 21, 2023 BREA, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces its achievement of a key milestone with full approval from the Environmental Protection Agency (“EPA”) with certification for Class 3 EV Commercial Vehicles received on Sept. 22, 2023. Class 3 vehicle production began in August...